BMJ Evidence-Based Medicine

Evolution of evidence on overall survival benefits of cancer drugs included on the national reimbursement drug list of China, 2005–2022: an observational study

Objective To assess evidence of overall survival (OS) benefits of cancer drugs listed in China’s National Reimbursement Drug ...
ebm.bmj

Current Issue

Correction: Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial (12 June, 2024) Free ...
ebm.bmj

Addressing misleading medical information on social media: a scoping review of current interventions

Background Misleading information about medical products on social media may cause overuse. Objectives Explore interventions targeting the problem of misleading medical information and marketing on ...
ebm.bmj

Tramadol versus placebo for chronic pain: a systematic review with meta-analysis and trial sequential analysis

Objectives The objective of our study was to assess the benefits and harms of tramadol vs placebo in adults with chronic pain. Design The research method was a systematic review of randomised clinical ...
ebm.bmj

Health technology assessment in India in the next decade: reflections on a vision for its path to maturity and impact

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj

AI-driven speech biomarkers for disease diagnosis and monitoring: a systematic review and meta-analysis

Objective This study aims to comprehensively review the literature on the use of speech biomarkers in disease diagnosis and monitoring, focusing on recording protocols, speech tasks, speech features ...
ebm.bmj

Cancer screening attendance rates in transgender and gender-diverse patients: a systematic review and meta-analysis

Objectives To examine disparities in attendance rates at cancer screening services between transgender and gender-diverse (TGD) people in comparison with their cisgender (CG) counterparts, and to ...
ebm.bmj

Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane

Correspondence to Dr Kerry Dwan, Centre for Reviews and Dissemination, University of York, York, UK; Kerry.dwan{at}york.ac.uk A systematic review identifies, appraises and synthesises all the ...
ebm.bmj

Expanding the evidence within evidence-based healthcare: thinking about the context, acceptability and feasibility of interventions

1 School of Life and Health Sciences, Aston University, Birmingham, West Midlands, UK 2 School of Psychology, University of Birmingham, Edgbaston, Birmingham, West Midlands, UK Thus, interpersonal ...
ebm.bmj

Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision ...

Introduction: High-quality randomised controlled trials (RCTs) provide the most reliable evidence on the comparative efficacy of new medicines. However, non-randomised studies (NRS) are increasingly ...
ebm.bmj

Digital aripiprazole or digital evergreening? A systematic review of the evidence and its dissemination in the scientific literature and in the media

Background In November 2017, the Food and Drug Administration (FDA) approved a version of a second-generation antipsychotic, aripiprazole, embedded with a sensor (Abilify MyCite). Objective To ...